The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref.RDRBG20251022009. Una PYME búlgara busca socios para la convocatoria de Horizonte Europa «Integración del transporte por vías navegables interiores en el transporte marítimo inteligente y las cadenas logísticas multimodales» HORIZON-CL5-2026-01-D6-10.
A Bulgarian company with over 50 years of experience in maritime transport, ship-generated waste management, and oil spill prevention and response is looking for a consortium to apply under the Horizon Europe call "Integrating inland waterway transport into smart...
Oct 24, 2025
















